Ignite Creation Date:
2025-12-24 @ 7:56 PM
Ignite Modification Date:
2025-12-30 @ 2:32 AM
Study NCT ID:
NCT01271504
Status:
COMPLETED
Last Update Posted:
2021-05-12
First Post:
2011-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma
Sponsor:
Eisai Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-07-19
Start Date Type:
ACTUAL
Primary Completion Date:
2015-06-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-06-23
Completion Date Type:
ACTUAL
First Submit Date:
2011-01-05
First Submit QC Date:
None
Study First Post Date:
2011-01-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-03-10
Results First Submit QC Date:
None
Results First Post Date:
2021-04-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-16
Last Update Post Date:
2021-05-12
Last Update Post Date Type:
ACTUAL